← SynDRA
MENAQUINONE 7
SynDRA canonical compound SYN0024161 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TNFRSF11B |
|---|
| Mechanism of action | osteoclast inhibitor |
|---|
| Indication | arteriosclerosis |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
Cross-references
Synonyms
- Menaquinone-7
- Menakinon 7
- Menaquinone k7
- Vitamin k2(35)
- Vitamin mk 7
- Vitamin K2(35)
- Menaquinone K7
- Vitamin MK 7
- CHEBI:44245
- RefChem:925473
- DTXCID90908566
- MK-7
- MFCD06200757
- Mk7
- Menaquinone 7, Synthetic (90%)
- Menaquinone K
- Menlaquinone 7
- HSDB 1040
- menaquinone(7)
- Menaquinone MK-7
- C46H64O2
- trans-menaquinone 7
- Vitamin K2-7
- Vitamin K2 (MK-7)
- Menaquinone-7 (Standard)
- UNII-8427BML8NY
- MENAQUINONE 7 [MI]
- MENAQUINONE-7 [DSC]
- MENAQUINONE 7 [HSDB]
- SCHEMBL436068
- MENAQUINONE-7 [USP-RS]
- MENAQUINONE-7 [WHO-DD]
- SCHEMBL29359122
- MSK1597
- Vitamin K2 Menaquinone-7 (MK-7)
- AKOS027326821
- FM25056
- HY-112499R
- AC-36642
Look up MENAQUINONE 7 in the interactive SynDRA portal →